dansylarginine N-(3-ethyl-1,5-pentanediyl)amide

fluorescent inhibitor of thrombin; structure

Also Known As:

DAPA Dns-Arg; Piperidine, 1-(5-((aminoiminomethyl)amino)-2-(((5-(dimethylamino)-1-naphthalenyl)sulfonyl)amino)-1-oxopentyl)-4-ethyl-, (S)-

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Neuroblastoma 08/05/1983 - "Thrombin, the central regulatory enzyme in coagulation, when incubated in nanomolar concentrations with murine neuroblastoma cells produced a rapid and marked increase in tritiated guanosine 3',5'-monophosphate (cyclic GMP) formation that was blocked by hirudin and competitively antagonized by dansylarginine N-(3-ethyl-1,5-pentanediyl)amide. "
2.	Neoplasms (Cancer) 11/01/1981 - "Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor, dansylarginine N-(3-ethyl-1,5-pentanediyl)amide."
3.	Adenocarcinoma 11/01/1981 - "Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor, dansylarginine N-(3-ethyl-1,5-pentanediyl)amide."